Tizanidine
| Amazina | |
|---|---|
| Amazina y'ubucuruzi | Zanaflex, Sirdalud, n'indi |
| Amakuru y'ubuvuzi | |
| Uko ufatwa | Mu kanwa |
| Ihuza ryo hanze | |
| MedlinePlus | a601121 |
| Ibiranga | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Kode ya ATC |
|
| Amakuru y'ubutabire | |
| Formule | C9H8ClN5S |
| Uburemere bwa mole | 25371 g·mol−1 |
Tizanidine, igurishwa ku mazina nka Zanaflex, ni umuti woroshya imitsi ukoreshwa mu kuvura imitsi ifunganye bitewe n'imvune y'umugongo cyangwa multiple sclerosis. Ifatwa mu kanwa, kandi yemerewe gukoreshwa mu buvuzi muri Leta Zunze Ubumwe za Amerika mu 1996.
Ikoreshwa mu buvuzi
[Hindura | hindura inkomoko]
Tizanidine, igurishwa ku izina rya Zanaflex n'indi, ni umuti ukoreshwa mu kuvura imitsi idakora neza bitewe n'imvune y'umugongo cyangwa multiple sclerosis.[1] Kugira ingaruka ku mikorere bisa nka baclofen cyangwa diazepam.[2] Ifatwa mu kanwa.[3]
Ingaruka mbi n'uko ikora
[Hindura | hindura inkomoko]Ingaruka mbi zikunze kugaragara zirimo kuma mu kanwa, gusinzira, gucika intege, no kuzerera.[3] Ingaruka mbi zishobora kuba zirimo umuvuduko muke w'amaraso, ibibazo by'umwijima, indwara yo mu mutwe, no kwangirika k'umuvuduko wa QT.[3] Ntabwo birasobanuka neza niba gukoresha imiti mu gihe cyo gutwita no konsa ari nta kibazo.[4] Ni agonisti ya α2-adrenergic kandi uburyo ikora ntibusobanutse neza.[3]
Amateka n'igiciro
[Hindura | hindura inkomoko]Tizanidine yemerewe gukoreshwa mu buvuzi muri Leta Zunze Ubumwe za Amerika mu 1996.[3] Iraboneka nk'umuti usanzwe.[1] Ku kwezi mu Bwongereza bitwara NHS amafaranga agera kuri 3.45 £ mu 2019.[1] Muri Leta Zunze Ubumwe za Amerika, ikiguzi cy'iyi ngano ni hafi amadolari y'Amerika 4.20.[5] Mu 2017, wari umuti wa 89 watanzwe cyane muri Leta Zunze Ubumwe za Amerika, aho wanditswe n'abaganga barenga miliyoni icyenda.[6][7]
Inyandiko
[Hindura | hindura inkomoko]- 1 2 3 British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 1094. ISBN 9780857113382.
- ↑ Kamen L, Henney HR, Runyan JD (February 2008). "A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury". Current Medical Research and Opinion. 24 (2): 425–39. doi:10.1185/030079908X261113. PMID 18167175.
- 1 2 3 4 5 "Tizanidine Hydrochloride Monograph for Professionals". Drugs.com (in Icyongereza). American Society of Health-System Pharmacists. Archived from the original on 16 June 2019. Retrieved 3 March 2019.
- ↑ "Tizanidine Pregnancy and Breastfeeding Warnings". Drugs.com (in Icyongereza). Archived from the original on 3 December 2018. Retrieved 3 March 2019.
- ↑ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services (in Icyongereza). Archived from the original on 6 March 2019. Retrieved 3 March 2019.
- ↑ "The Top 300 of 2020". ClinCalc. Archived from the original on 18 March 2020. Retrieved 11 April 2020.
- ↑ "Tizanidine - Drug Usage Statistics". ClinCalc. Archived from the original on 8 July 2020. Retrieved 11 April 2020.
Reba kandi
[Hindura | hindura inkomoko]Ingingo zijyanye
[Hindura | hindura inkomoko]Ihuza ryo hanze
[Hindura | hindura inkomoko]- "Tizanidine". MedlinePlus (in Icyongereza).